Filing Details
- Accession Number:
- 0000939767-24-000161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-19 20:03:11
- Reporting Period:
- 2024-11-15
- Accepted Time:
- 2024-11-19 20:03:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Biological Products, (No Disgnostic Substances) (2836) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1692954 | J. Patrick Haley | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Evp, Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-11-15 | 14,672 | $35.05 | 330,253 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-11-18 | 22,207 | $34.31 | 308,046 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-18 | 19,381 | $34.41 | 288,665 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 23,539 | Indirect | By spouse |
| Common Stock | 10,648 | Indirect | By 401(k) |
Footnotes
- Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 11, 2020, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on September 6, 2023.
- Includes 210,622 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economicequivalent of one share of Common Stock.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.11 to $34.48. Reporting Person undertakes to provide Exelixis, Inc., any securityholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote 4 to this Form 4.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.40 to $34.45. Reporting Person undertakes to provide Exelixis, Inc., any securityholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote 5 to this Form 4.
- Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 14, 2024.
Billionaire Hedge Funds
